AI
AVXL icon

Atria Investments’s Anavex Life Sciences AVXL Stock Holding History

Atria Investments’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Buy
33,229
+9,889
+42% +$42.8K ﹤0.01% 2007
2025
Q4 		$83.1K Buy
23,340
+2,429
+12% +$14.9K ﹤0.01% 2011
2025
Q3 		$186K Sell
20,911
-1,199
-5% -$12.2K ﹤0.01% 1961
2025
Q2 		$204K Buy
22,110
+3,406
+18% +$29.1K ﹤0.01% 1919
2025
Q1 		$160K Sell
18,704
-3,980
-18% -$37.6K ﹤0.01% 1849
2024
Q4 		$244K Buy
22,684
+9,384
+71% +$72.2K ﹤0.01% 1697
2024
Q3 		$75.5K Buy
+13,300
New +$76.7K ﹤0.01% 1881

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM